SINGAPORE – Several talks and forums at the recent Phar-East Pharma and Biotech Festival focused on funding and its relation to the ecosystem in Asia. Naturally, much of this discussion centered on Singapore, the host country for the event and the most developed biotech and med-tech hub in Southeast Asia. Tong Hsien-Hui, head of venture investing at SGInnovate, said it makes sense for Singapore, given its size, to build its ecosystem to focus on niches.